IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Developing in-licensed immunotherapies for asthma and other indications.
Industry: Health Care
Latest Trade: $9.58 +0.18 (+1.9%)
First Day Return: +12.1%
Return from IPO: -41.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 12/21/2018 |
Offer Price | $16.00 |
Price Range $16.00 - $16.00 | |
Offer Shares (mm) | 17.3 |
Deal Size ($mm) | $276 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/07/2019 |
Offer Price | $16.00 |
Price Range $16.00 - $16.00 | |
Offer Shares (mm) | 17.3 |
Deal Size ($mm) | $276 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
more |
Company Data | |
---|---|
Headquarters | San Diego, CA |
Founded | 2015 |
Employees | 105 |
Website www.gossamerbio.com |